DBV Technologies Priced, Nasdaq: DBVT

French biotech developing immunotherapy patches that treat food allergies.

Industry: Health Care

Latest Trade: $34.65 -0.17 (-0.5%)

First Day Return: +5.8%

Return from IPO: +60.9%

Industry: Health Care

French biotech developing immunotherapy patches that treat food allergies.
more less
IPO News for DBV Technologies
more
IPO Data
IPO File Date 09/23/2014
Offer Price $21.64
Price Range $23.00 - $23.00
Offer Shares (mm) 4.3
Deal Size ($mm) $93
IPO Data
IPO Date 10/21/2014
Offer Price $21.64
Price Range $23.00 - $23.00
Offer Shares (mm) 4.3
Deal Size ($mm) $93
Underwriters
more
Company Data
Headquarters Bagneux, France
Founded 2002
Employees 47
Website www.dbv-technologies.com